CSL - Des Atouts





Des Atouts Changement Date
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Arca Biopharma USD 504.48M 15.86M 2026-03
aTyr Pharma USD 79.65M 435.68M 2026-03
Bio Path USD 677K 13K 2026-03
Brainstorm Cell Therapeutics USD 755K 267K 2026-03
Cara Therapeutics USD 32.07M 6.95M 2025-12
CSL USD 37.9B 1.5B 2025-12
Curis USD 19.97M 9.27M 2025-12
Esperion Therapeutics USD 462.53M 3.36M 2026-03
Immunic USD 189.74M 165.69M 2026-03
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
TherapeuticsMD USD 40.13M 1.96M 2024-06